Requirement for Parp-1 and DNA ligases 1 or 3 but not of Xrcc1 in chromosomal translocation formation by backup end joining.
about
Alternative Okazaki Fragment Ligation Pathway by DNA Ligase IIIDNA Damage and Pulmonary HypertensionA moonlighting metabolic protein influences repair at DNA double-stranded breaks.PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directionsMicrohomology-Mediated End Joining: A Back-up Survival Mechanism or Dedicated Pathway?PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA.Chromosomal translocations in human cells are generated by canonical nonhomologous end-joining.Poly (ADP-ribose) polymerase inhibitors: recent advances and future development.Human DNA ligase III bridges two DNA ends to promote specific intermolecular DNA end joiningA role for human homologous recombination factors in suppressing microhomology-mediated end joiningMechanistic Modelling and Bayesian Inference Elucidates the Variable Dynamics of Double-Strand Break Repair.Rad51 in regulating the radiosensitivity of non-small cell lung cancer with different epidermal growth factor receptor mutation status.Ligase I and ligase III mediate the DNA double-strand break ligation in alternative end-joining.Risky business: Microhomology-mediated end joining.Biology of high single doses of IORT: RBE, 5 R's, and other biological aspectsA flow cytometry-based method to simplify the analysis and quantification of protein association to chromatin in mammalian cells.Understanding the DNA damage response in order to achieve desired gene editing outcomes in mosquitoes.Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all.Programmed DNA breaks in lymphoid cells: repair mechanisms and consequences in human diseaseIdentifying high-risk adult AML patients: epigenetic and genetic risk factors and their implications for therapy.Chlorpyrifos Induces MLL Translocations Through Caspase 3-Dependent Genomic Instability and Topoisomerase II Inhibition in Human Fetal Liver Hematopoietic Stem Cells.DNA Ligases I and III Support Nucleotide Excision Repair in DT40 Cells with Similar Efficiency.Association Between the LIG1 Polymorphisms and Lung Cancer Risk: A Meta-analysis of Case-Control Studies.Genomic rearrangements induced by unscheduled DNA double strand breaks in somatic mammalian cells.Chromosome thripsis by DNA double strand break clusters causes enhanced cell lethality, chromosomal translocations and 53BP1-recruitment.DNA polymerase beta participates in DNA End-joining.Deregulated BCL-2 family proteins impact on repair of DNA double-strand breaks and are targets to overcome radioresistance in lung cancer.Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma.Repair of DNA double-strand breaks by mammalian alternative end-joining pathways.Progression of chromosomal damage induced by etoposide in G2 phase in a DNA-PKcs-deficient context.PARP1 is required for preserving telomeric integrity but is dispensable for A-NHEJ
P2860
Q26853144-1A519868-AECB-4D28-B4AC-D2A09E88A4CEQ27005594-DCA5F533-E4B7-4F68-8D34-DB17FBF17C27Q27935930-F0732629-81D1-49BA-8640-A151387B436FQ28071345-CAF70700-D074-452F-8C0E-632834DDE84EQ28083182-0E5705F1-F61C-4EC2-B57E-D53F8A310F63Q33629904-5F4CEF8F-08C3-4B47-9CE8-4BEA745477DBQ35243380-C91F17D0-60FA-41AC-92FC-36A20B573925Q35895214-278FD578-C11A-44F4-8D29-FE9159AB510AQ35961937-D49EA5C2-E8CB-4A73-9798-E0072AD9C78FQ36004169-96754D26-17CB-45BA-94B7-9D6963D31A3FQ36163627-ADBE41AE-CF83-4F71-A938-AC3585888756Q36477745-EAB47639-7F9B-45EB-AD03-F81496AD3479Q36563447-E11DA917-C50F-4DF6-AA2F-97FEAFBA0650Q36952240-C8B944F3-DED7-4ED3-A2B3-1A383CB3C553Q37597275-E776CF22-4B3F-4809-9593-A1CE30444803Q38267277-319F8869-6BF9-414F-AADD-09AB9231C75EQ38321939-1BAC0539-3F71-4C9F-BB45-7F4429A94142Q38561332-709E255C-AD35-4176-8AA7-70ED9F0590E5Q38604020-A5430E07-2584-4015-8E5E-F4823FBEDBDBQ38694866-FF4B9116-5560-408C-A7CA-C3750877521BQ38850697-360D5714-D8FA-4DE9-9F55-ECF78621D050Q38858211-EDDB9275-E605-40F6-9023-BD577755A8A0Q38879645-AFF78F71-ABA6-453D-A746-4DA438E9BEC9Q39154178-D3199473-5A83-4161-9743-1E55EEBCCC55Q41117288-7A118CC1-5BFD-45F2-9904-46794077D43FQ47378572-5D488E44-DA05-4E02-9E83-2368E554C806Q50654488-5BD46540-D230-476B-B73A-87B9CDE8040CQ52327430-95C539CC-59B8-4DB6-8711-040F53391A81Q52659674-19F84025-FA91-43C5-8DAA-10EB855F3C72Q54260671-EA4BA1B7-E2F5-4870-8067-37E53B786558Q58582587-4EC09C6A-8A5A-4056-8E19-399E9CCA3135
P2860
Requirement for Parp-1 and DNA ligases 1 or 3 but not of Xrcc1 in chromosomal translocation formation by backup end joining.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Requirement for Parp-1 and DNA ...... rmation by backup end joining.
@ast
Requirement for Parp-1 and DNA ...... rmation by backup end joining.
@en
type
label
Requirement for Parp-1 and DNA ...... rmation by backup end joining.
@ast
Requirement for Parp-1 and DNA ...... rmation by backup end joining.
@en
prefLabel
Requirement for Parp-1 and DNA ...... rmation by backup end joining.
@ast
Requirement for Parp-1 and DNA ...... rmation by backup end joining.
@en
P2093
P2860
P356
P1476
Requirement for Parp-1 and DNA ...... rmation by backup end joining.
@en
P2093
Aashish Soni
Gabriel E Pantelias
George Iliakis
Maria Siemann
Martha Grabos
Tamara Murmann
P2860
P304
P356
10.1093/NAR/GKU298
P407
P577
2014-04-19T00:00:00Z